You just read:

Medimetriks Announces Phase 2 Study Results Demonstrating Early Itch Relief for Topical PDE4 Inhibitor MM36 in Patients with Atopic Dermatitis

News provided by

Medimetriks Pharmaceuticals, Inc.

Sep 06, 2017, 06:36 ET